This information collection supports Food and Drug Administration regulations governing applications for FDA approval to market a new drug. Respondents to the collection are individuals or entities submitting such applications to the agency in accordance with the provisions found in the Code of Federal Regulations (CFR), Title 21, Part 314.
The latest form for Applications for FDA Approval to Market a New Drug expires 2021-03-31 and can be found here.
Document Name |
---|
Form and Instruction |
Form |
Supporting Statement A |
Justification for No Material/Nonsubstantive Change |
Federal Enterprise Architecture: Health - Public Health Monitoring
Form 2252 | Transmittal of Annual Report for Drug and Biologics for Human Use | Fillable Fileable | Form |
Form FDA 3331a | NDA - Field Alert Report | www.fda.gov/drugs/surveillance/field-alert-reports | Form and instruction |
Form 356 | Application to Market a New or Abbreviated New Drug or Biologic for Human Use | Fillable Fileable | Form |
Form 2253 | Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use | Fillable Fileable | Form |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.